Early T‐cell precursor lymphoblastic leukaemia: response to FLAG‐IDA and high‐dose cytarabine with sorafenib after initial refractoriness.

The article presents several case studies related to early T-cell precursor lymphoblastic leukaemia. It discussed the conditions of patients including a 31-year-old man, presented with a mediastinal mass and white blood cell (WBC) count, without central nervous system (CNS) involvement; a 34-year-old man who presented with pancytopenia; and a 39-year-old man, presented with a mediastinal mass and presence of 0.6 percent leukaemic cells.